Stockholders' Equity (Details Narrative) - USD ($)
|
3 Months Ended |
|
May 31, 2017 |
May 31, 2016 |
Feb. 28, 2017 |
| Proceeds from sales of common shares |
$ 5,897,188
|
$ 1,988,003
|
|
| Issuance of common shares for cash, Price per share |
1,123,266
|
|
|
| Issuance of common shares for cash, Per Shares |
$ 5.25
|
|
|
| Issuance of warrants to purchase |
1,860,455
|
1,653,668
|
1,647,670
|
| Warrants |
|
|
|
| Issuance of warrants to purchase |
314,667
|
|
|
| Exercise Price of Warrants |
$ 0.80
|
|
|
| Fair value of stock granted |
$ 874,125
|
|
|
| Shares issued for cash-less exercise warrant |
20,000
|
|
|
| Issuance of shares upon cash-less exercise of warrants, Shares |
22,548
|
|
|
| Amortized costs included in operating expenses |
$ 220,504
|
$ 41,359
|
|
| Unamortized balance of costs |
3,377,143
|
|
|
| Aggregate intrinsic value outstanding |
$ 9,325,489
|
|
|
| Closing market price per share |
$ 8.05
|
|
|
| Warrants | Chief Financial Officer [Member] |
|
|
|
| Issuance of warrants to purchase |
400,000
|
|
|
| Exercise Price of Warrants |
$ 5.25
|
|
|
| Vesting period |
10 years
|
|
|
| Description of vesting period |
Vests quarterly in equal amounts over 24 months beginning on April 3, 2017.
|
|
|
| Common stock reserved for future issuance |
150,000
|
|
|
| Fair value of stock granted |
$ 2,331,000
|
|
|